| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addressing a system failure to diagnose COPD and asthma
|
Roberts, C Michael
|
|
|
9 |
8 |
p. 814-816
|
artikel
|
| 2 |
Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial
|
Wallis, Robert S
|
|
|
9 |
8 |
p. 897-908
|
artikel
|
| 3 |
A leap forward in assessing host-directed therapies for tuberculosis
|
Ignatius, Elisa H
|
|
|
9 |
8 |
p. 809-810
|
artikel
|
| 4 |
Artificial intelligence hold promise in the ICU
|
Burki, Talha Khan
|
|
|
9 |
8 |
p. 826-828
|
artikel
|
| 5 |
Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study
|
Aveyard, Paul
|
|
|
9 |
8 |
p. 909-923
|
artikel
|
| 6 |
Association between sex and SARS-CoV-2 infection and hospitalisation as a result of COVID-19
|
Adir, Yochai
|
|
|
9 |
8 |
p. e75-e76
|
artikel
|
| 7 |
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial
|
Tardif, Jean-Claude
|
|
|
9 |
8 |
p. 924-932
|
artikel
|
| 8 |
Correction to Lancet Respir Med 2021; published online June 17, https://doi.org/10.1016/S2213-2600(21)00237-X
|
|
|
|
9 |
8 |
p. e84
|
artikel
|
| 9 |
COVID-19 and ECMO: a call for close cooperation and more investigation
|
Lorusso, Roberto
|
|
|
9 |
8 |
p. 805-807
|
artikel
|
| 10 |
COVID-19 hospital admissions: Brazil's first and second waves compared
|
Bastos, Leonardo SL
|
|
|
9 |
8 |
p. e82-e83
|
artikel
|
| 11 |
COVID-19 vaccination in patients with α1-antitrypsin deficiency
|
Yang, Chengliang
|
|
|
9 |
8 |
p. 818-820
|
artikel
|
| 12 |
Cytokine adsorption and ECMO in patients with COVID-19
|
Nardelli, Pasquale
|
|
|
9 |
8 |
p. e71
|
artikel
|
| 13 |
Cytokine adsorption and ECMO in patients with COVID-19
|
Rybalko, Andrey
|
|
|
9 |
8 |
p. e69-e70
|
artikel
|
| 14 |
Cytokine adsorption and ECMO in patients with COVID-19 – Author's reply
|
Supady, Alexander
|
|
|
9 |
8 |
p. e72-e74
|
artikel
|
| 15 |
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial
|
Bauer, Axel
|
|
|
9 |
8 |
p. 863-872
|
artikel
|
| 16 |
E-cigarettes for smoking reduction: a piece of the public health puzzle
|
Choi, Kelvin
|
|
|
9 |
8 |
p. 804-805
|
artikel
|
| 17 |
Effect of an electronic nicotine delivery system with 0, 8, or 36 mg/mL liquid nicotine versus a cigarette substitute on tobacco-related toxicant exposure: a four-arm, parallel-group, randomised, controlled trial
|
Cobb, Caroline O
|
|
|
9 |
8 |
p. 840-850
|
artikel
|
| 18 |
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study
|
Shi, Yuankai
|
|
|
9 |
8 |
p. 829-839
|
artikel
|
| 19 |
Exploiting an early immunological window of opportunity in COVID-19
|
Russell, Clark D
|
|
|
9 |
8 |
p. 811-812
|
artikel
|
| 20 |
Extracorporeal membrane oxygenation for COVID-19 during first and second waves
|
Broman, Lars Mikael
|
|
|
9 |
8 |
p. e80-e81
|
artikel
|
| 21 |
Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study
|
Lebreton, Guillaume
|
|
|
9 |
8 |
p. 851-862
|
artikel
|
| 22 |
Fighting for air: racial inequity in respiratory health
|
The Lancet Respiratory Medicine,
|
|
|
9 |
8 |
p. 803
|
artikel
|
| 23 |
I won't let cystic fibrosis stop me from living my best life
|
Baxter, Lucy
|
|
|
9 |
8 |
p. 823-824
|
artikel
|
| 24 |
Lifting of COVID-19 restrictions in the UK and the Delta variant
|
Burki, Talha Khan
|
|
|
9 |
8 |
p. e85
|
artikel
|
| 25 |
Misconceptions regarding symptoms of sarcoidosis
|
Drent, Marjolein
|
|
|
9 |
8 |
p. 816-818
|
artikel
|
| 26 |
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study
|
Keir, Holly R
|
|
|
9 |
8 |
p. 873-884
|
artikel
|
| 27 |
Ongoing asthma management in children during the COVID-19 pandemic: to step down or not to step down?
|
Abrams, Elissa Michele
|
|
|
9 |
8 |
p. 820-822
|
artikel
|
| 28 |
Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19
|
Ceulemans, Laurens J
|
|
|
9 |
8 |
p. e78-e79
|
artikel
|
| 29 |
RAS inhibition and COVID-19: more questions than answers?
|
Kerneis, Mathieu
|
|
|
9 |
8 |
p. 807-809
|
artikel
|
| 30 |
Recovery after prolonged ICU treatment in patients with COVID-19
|
Parotto, Matteo
|
|
|
9 |
8 |
p. 812-814
|
artikel
|
| 31 |
Research priorities for exacerbations of COPD
|
Alqahtani, Jaber S
|
|
|
9 |
8 |
p. 824-826
|
artikel
|
| 32 |
Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?
|
Raut, Akshay
|
|
|
9 |
8 |
p. e77
|
artikel
|
| 33 |
The Berlin definition of acute respiratory distress syndrome: should patients receiving high-flow nasal oxygen be included?
|
Matthay, Michael A
|
|
|
9 |
8 |
p. 933-936
|
artikel
|
| 34 |
The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study
|
Dicker, Alison J
|
|
|
9 |
8 |
p. 885-896
|
artikel
|
| 35 |
WHO's Tobacco Taxation Manual 2.0
|
Balakrishnan, Vijay Shankar
|
|
|
9 |
8 |
p. e86-e87
|
artikel
|
Tijdschrift beschrijving